View as an RSS Feed
View H.S. Ayoub's Articles BY TICKER:
ACCP, ACOR, AGN, ALGN, AMGN, ANIK, ARQL, AUXL, AVXL, BAX, BJGP, BMRN, BNT, BRKR, BSC, BUF, BVF, CARN, CAXG, CELG, CEPH, CNIC, CNU, CORT, CRXL, CYTC, DNDN, DRRX, DVAX, EPCT, EPRS, GERN, GNBT, GNTAQ, GSK, HQL, HSKA, IDMI, INSV, IVGN, KDUS, KOOL, MCUJD, MRK, MSTX, NFLX, NSTK, NVAX, NVD, OGEN, ONXX, OPK, OXGN, PFE, PGLA, PLX, POLXF, PTIE, PVCT, PXSL, RGEN, RHHBY, RITA, SDIX, SIGA, SIRI, SMTS, STEM, TGEN, THOR, TRGT, VION, VNDA, VRTX, VVUS, VXGN
- Cephalon’s New CLL Drug Should Please Patients and Investors
- U.S. No Longer Epicenter of the Financial World
- Anavex Life Sciences Takes Cues from FDA in Combating Major Diseases
- Allergan Drops Unnecessarily on FDA BOTOX Review
- IDM Pharma Jumps 234% After Major "Coincidence"
- Somanetics Jumps on Volume Spike
- Hepatitis C Developments Drag Biotechs Down
- GlaxoSmithKline Heads 2007 Most Ethical Pharmas List
- Big Pharma Couples with Biotech: Marriage Made in Hell?
- Aoxing Pharmaceutical's Anti-Opioid Addiction Drug Approved by China’s FDA
- Protalix Stock Collapses On Unexplained Pricing of New Shares
- Inverview With Jonathan Houssian, RxElite Founder: We're "A Significant Growth Investment"
- Adventrx Plummets 80% On Cancer Drug Trial Results
Interview: Pluristem Life Systems VP Dr. Prather
Sep. 16, 2007 • Comment!
- Dendreon Has Competition: Northwest BioTherapeutics Gains Cancer Vaccine Approval
- Dendreon: Media Spotlight Generates Hype and Hysteria
- Dendreon Jumps on New Cancer Vaccine Report
- Investment Opportunities In Healthcare: An Interview With Alan Brochstein
- Corcept Stock Continues To Rally On Weight Loss News
- Why Did Protalix's Stock Offering Announcement Boost Shares?
Are China's Recent Changes In Health Policy A Pre-Olympics Tactic?
Jun. 14, 2007 • Comment!
- Strategic Diagnostics Jumps on Volume Spike
- Vion Plunges 60 Percent Following Tuesday's Jump
- Tiny Biotech Vion Jumps on Strong Volume, No News
- GE Healthcare, Heads Up: Thermogenesis Would Make A Great Buy
- ArQule Could Gain Ahead of American Society of Clinical Oncology Meeting
- Biotech Buyout Frenzy Continues
- Bruker BioSciences Plunges On Market Over-Reaction
- Align Technology Blows Past Estimates
AlphaMD: An Investor's Link to the Medical World
Apr. 25, 2007 • Comment!
- Tiny Provectus Pharmaceuticals Jumps 15% on 6x Volume
- Oxigene Gains 7% on 10x Volume